Thrombin generation and fibrinolysis in anti-factor IX treated blood and plasma spiked with factor VIII inhibitor bypassing activity or recombinant factor VIIa. | Haemophilia;16(3): 510-7, 2010 May. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Thrombin generation and fibrinolysis in anti-factor IX treated blood and plasma spiked with factor VIII inhibitor bypassing activity or recombinant factor VIIa.

Bolliger, D; Szlam, F; Molinaro, R J; Escobar, M A; Levy, J H; Tanaka, K A.

Affiliation

Bolliger D; Department of Anesthesiology, Emory University School of Medicine, Atlanta, GA, USA.

Haemophilia ; 16(3): 510-7, 2010 May.

Article in En | MEDLINE | ID: mdl-20050927

Subject(s)

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Blood Coagulation / Blood Coagulation Factors / Thrombin / Factor VIIa / Factor IXa / Hemophilia A Type of study: Prognostic_studies Limits: Humans Language: En Journal: Haemophilia Journal subject: HEMATOLOGIA Year: 2010 Document type: Article Affiliation country: Country of publication:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Blood Coagulation / Blood Coagulation Factors / Thrombin / Factor VIIa / Factor IXa / Hemophilia A Type of study: Prognostic_studies Limits: Humans Language: En Journal: Haemophilia Journal subject: HEMATOLOGIA Year: 2010 Document type: Article Affiliation country: Country of publication: